127 related articles for article (PubMed ID: 23740878)
1. α-L-fucosidase inhibition by pyrrolidine-ferrocene hybrids: rationalization of ligand-binding properties by structural studies.
Hottin A; Wright DW; Steenackers A; Delannoy P; Dubar F; Biot C; Davies GJ; Behr JB
Chemistry; 2013 Jul; 19(29):9526-33. PubMed ID: 23740878
[TBL] [Abstract][Full Text] [Related]
2. Iminosugar-ferrocene conjugates as potential anticancer agents.
Hottin A; Dubar F; Steenackers A; Delannoy P; Biot C; Behr JB
Org Biomol Chem; 2012 Aug; 10(29):5592-7. PubMed ID: 22717621
[TBL] [Abstract][Full Text] [Related]
3. A second-generation ferrocene-iminosugar hybrid with improved fucosidase binding properties.
Hottin A; Scandolera A; Duca L; Wright DW; Davies GJ; Behr JB
Bioorg Med Chem Lett; 2016 Mar; 26(6):1546-1549. PubMed ID: 26897594
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the hydrophobic terrain in fucosidases with aryl-substituted pyrrolidine iminosugars.
Hottin A; Wright DW; Davies GJ; Behr JB
Chembiochem; 2015 Jan; 16(2):277-83. PubMed ID: 25427942
[TBL] [Abstract][Full Text] [Related]
5. Three dimensional structure of a bacterial α-l-fucosidase with a 5-membered iminocyclitol inhibitor.
Wright DW; Moreno-Vargas AJ; Carmona AT; Robina I; Davies GJ
Bioorg Med Chem; 2013 Aug; 21(16):4751-4. PubMed ID: 23830696
[TBL] [Abstract][Full Text] [Related]
6. The 'mirror-image' postulate as a guide to the selection and evaluation of pyrrolidines as α-l-fucosidase inhibitors.
Stocker BL; Jongkees SA; Win-Mason AL; Dangerfield EM; Withers SG; Timmer MS
Carbohydr Res; 2013 Feb; 367():29-32. PubMed ID: 23295913
[TBL] [Abstract][Full Text] [Related]
7. Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines.
Hottin A; Carrión-Jiménez S; Moreno-Clavijo E; Moreno-Vargas AJ; Carmona AT; Robina I; Behr JB
Org Biomol Chem; 2016 Mar; 14(12):3212-20. PubMed ID: 26906450
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
[TBL] [Abstract][Full Text] [Related]
9. Exploring the divalent effect in fucosidase inhibition with stereoisomeric pyrrolidine dimers.
Hottin A; Wright DW; Moreno-Clavijo E; Moreno-Vargas AJ; Davies GJ; Behr JB
Org Biomol Chem; 2016 May; 14(20):4718-27. PubMed ID: 27138139
[TBL] [Abstract][Full Text] [Related]
10. Spirocyclopropyl pyrrolidines as a new series of alpha-L-fucosidase inhibitors.
Laroche C; Behr JB; Szymoniak J; Bertus P; Schütz C; Vogel P; Plantier-Royon R
Bioorg Med Chem; 2006 Jun; 14(12):4047-54. PubMed ID: 16488612
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective synthesis of (2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol derivatives that are highly selective alpha-L-fucosidase inhibitors.
Moreno-Vargas AJ; Carmona AT; Mora F; Vogel P; Robina I
Chem Commun (Camb); 2005 Oct; (39):4949-51. PubMed ID: 16205810
[TBL] [Abstract][Full Text] [Related]
12. Harnessing pyrrolidine iminosugars into dimeric structures for the rapid discovery of divalent glycosidase inhibitors.
Carmona AT; Carrión-Jiménez S; Pingitore V; Moreno-Clavijo E; Robina I; Moreno-Vargas AJ
Eur J Med Chem; 2018 May; 151():765-776. PubMed ID: 29674295
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric synthesis of the L-fuco-nojirimycin, a nanomolar alpha-L-fucosidase inhibitor.
Dubernet M; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2006 Mar; 16(5):1172-4. PubMed ID: 16376079
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and fucosidase inhibitory study of unnatural pyrrolidine alkaloid 4-epi-(+)-codonopsinine.
Kotland A; Accadbled F; Robeyns K; Behr JB
J Org Chem; 2011 May; 76(10):4094-8. PubMed ID: 21495694
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of branched seven-membered 1-N-iminosugars and their evaluation as glycosidase inhibitors.
Li H; Zhang Y; Favre S; Vogel P; Sollogoub M; Blériot Y
Carbohydr Res; 2012 Jul; 356():110-4. PubMed ID: 22129839
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and inhibitory activities of novel C-3 substituted azafagomines: a new type of selective inhibitors of α-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Rodríguez-Carvajal MA; Robina I
Bioorg Med Chem; 2010 Jul; 18(13):4648-60. PubMed ID: 20570156
[TBL] [Abstract][Full Text] [Related]
18. The spirocyclopropyl moiety as a methyl surrogate in the structure of l-fucosidase and l-rhamnosidase inhibitors.
Pearson MS; Floquet N; Bello C; Vogel P; Plantier-Royon R; Szymoniak J; Bertus P; Behr JB
Bioorg Med Chem; 2009 Dec; 17(23):8020-6. PubMed ID: 19875298
[TBL] [Abstract][Full Text] [Related]
19. Glycosidase-substrate interactions analysis by STD-NMR spectroscopy: study of alpha-L-fucosidase.
Berteau O; Sandström C; Bielicki J; Anson DS; Kenne L
J Am Chem Soc; 2003 Dec; 125(50):15296-7. PubMed ID: 14664566
[TBL] [Abstract][Full Text] [Related]
20. Novel alpha-L-fucosidase inhibitors from the bark of Angylocalyx pynaertii (Leguminosae).
Asano N; Yasuda K; Kizu H; Kato A; Fan JQ; Nash RJ; Fleet GW; Molyneux RJ
Eur J Biochem; 2001 Jan; 268(1):35-41. PubMed ID: 11121099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
